UHS
Universal Health ServicesNYSEHealth CareMedical Care FacilitiesSnapshot 2026-05-08
As of May 8, 2026, UHS has a composite score of 31.0 and a signal label of "favorable." This score is influenced by a medium confidence level of 76.1 and reflects strengths in management (65.7) and quality (76.3), while momentum is notably low at 9.1. The analysis is provisional, indicating that the scores may change as new information becomes available.
Price
Daily closes from AlphaVantage. Earnings/event dots are placed inline.
Factor signals
Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.
Thesis
— is this a strong company over a 1–3 year hold?Why this rank
- Direction share1.00
- Slope (norm)-0.08
- Bonus0.00
Why this rank
Trailing four: 2024-Q3, 2025-Q1, 2025-Q2, 2025-Q3
Why this rank
Watch
— has something changed worth re-reading?Why this setup
EPS estimate $5.89 → $5.76 (-2.1% / 30d). 2 raised, 7 cut, 10 covering analysts.
0 upgrades, 0 downgrades / 30d, 7 maintained. 42% of analysts rate Buy.
6 PT revisions / 30d. Avg target 34.2% above current price.
0 positive, 1 negative / 30d. See F4 management tile for the event list.
F4 · Management deep-dive — recent events, stated priorities, guidance track record
Recent 8-K events
7 material events in the last 24 months — top 5 listed below.
Stated priorities
3 priorityies extracted from earnings transcripts (as of 2026-05-08).
- 1.Increase revenue forecastgrowthbehind0% progress
2/26: “Our 2026 forecasted range of net revenues $18.417 billion $18.789 billion.”
Why this status
Stated in 3 of last 3 quarters. Revenue guidance increased from $17,375 million in 2025 to $18,603 million in 2026, indicating a focus on growth. However, the financials show a decline in revenue from $4,495 million in 2025-Q3 to $3,205 million in 2025-Q4, suggesting limited progress in achieving this priority.
- 2.Maintain EPS growthgrowthbehind0% progress
2/26: “Our 2026 forecasted range of net income attributable to UHS, and EPS-diluted.”
Why this status
Stated in 3 of last 3 quarters. EPS guidance increased from $21.8 in 2025 to $23.58 in 2026, reflecting a focus on growth. However, diluted EPS declined from 5.86 in 2025-Q3 to null in 2025-Q4, indicating challenges in maintaining this growth trajectory.
- 3.Manage capital expenditurescapital allocationmixed30% progress
2/26: “Capital expenditures $950 million $1.1 billion.”
Why this status
Newly stated in 2025-Q4. Capex guidance is set between $950 million and $1.1 billion for 2026. The financials do not provide specific capex figures for comparison, making it difficult to assess progress. The focus remains on managing expenditures within this range.
Guidance track record
Insufficient guidance history for this ticker.
Position context
— how violent might the path be while I hold it?Why this risk level
Recent vol — 30d annualized 41%; 252d 33%.
Drawdown — Max 1y −33%. Bad day move −3%.
Beta to sector ETF (XLV) — 0.54 over 1y.
Liquidity — score 100/100.
Sub-scores — vol 45/100, drawdown 33/100, beta 54/100, earnings vol —.
via XLV
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-05-08.
What changed
The most important moves since the prior daily snapshot.
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-05-08
Management scorecard
How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
- #1
Increase revenue forecast
GrowthNew since 2026-05-04Focus on increasing the revenue forecast for the fiscal year 2026.
BehindStated in 3 of last 3 quarters. Revenue guidance increased from $17,375 million in 2025 to $18,603 million in 2026, indicating a focus on growth. However, the financials show a decline in revenue from $4,495 million in 2025-Q3 to $3,205 million in 2025-Q4, suggesting limited progress in achieving this priority.
0%CEO/CFO:“Our 2026 forecasted range of net revenues $18.417 billion $18.789 billion.”Multiple sourcesSource dated 2026-02-26Stated 3 of last 8 quartersFirst seen 2026-05-04Show history (3)
- 2025-Q4Multiple sources
“Our 2026 forecasted range of net revenues $18.417 billion $18.789 billion.”
- 2025-Q3Multiple sources
“we are increasing our operating results forecast range for consolidated net revenues.”
- 2025-Q2Multiple sources
“we are increasing our operating results forecast range for consolidated net revenues.”
- #2
Maintain EPS growth
GrowthNew since 2026-05-04Continue to focus on maintaining EPS growth through fiscal year 2026.
BehindStated in 3 of last 3 quarters. EPS guidance increased from $21.8 in 2025 to $23.58 in 2026, reflecting a focus on growth. However, diluted EPS declined from 5.86 in 2025-Q3 to null in 2025-Q4, indicating challenges in maintaining this growth trajectory.
0%CEO/CFO:“Our 2026 forecasted range of net income attributable to UHS, and EPS-diluted.”Multiple sourcesSource dated 2026-02-26Stated 3 of last 8 quartersFirst seen 2026-05-04Show history (3)
- 2025-Q4Multiple sources
“Our 2026 forecasted range of net income attributable to UHS, and EPS-diluted.”
- 2025-Q3Multiple sources
“we are increasing our operating results forecast range for... adjusted net income attributable to UHS per diluted share.”
- 2025-Q2Multiple sources
“we are increasing our operating results forecast range for... adjusted net income attributable to UHS per diluted share.”
- #3
Manage capital expenditures
Capital allocationNew since 2026-05-04Focus on managing capital expenditures within the forecasted range for 2026.
Behind →MixedNewly stated in 2025-Q4. Capex guidance is set between $950 million and $1.1 billion for 2026. The financials do not provide specific capex figures for comparison, making it difficult to assess progress. The focus remains on managing expenditures within this range.
30%CEO/CFO:“Capital expenditures $950 million $1.1 billion.”Multiple sourcesSource dated 2026-02-26Stated 1 of last 8 quartersFirst seen 2026-05-04Show history (1)
- 2025-Q4Multiple sources
“Capital expenditures $950 million $1.1 billion.”
How this stock is priced
Two ways to read price: against peers in the same business, and against the company's own history.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
P/E over the last 5 years
71 monthly pointsHow this compares
A side-by-side read on composite, valuation, and risk versus peers.
| Stock | Composite | Valuation | Risk |
|---|---|---|---|
UHS Universal Health Services | +31 | inexpensive | moderate |
LLY Lilly (Eli) | +21 | full | moderate |
JNJ Johnson & Johnson | +18 | full | low |
ABBV AbbVie | +12 | fair | low |
UNH UnitedHealth Group | +24 | fair | elevated |
Risk — how this stock moves
What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.
What could change this view
Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.
- If health_care sector trend rises from +0.06 into 'improving' (>= +0.20)+5.0 pts
- If next-quarter guidance is raised (currently NEW as of 2026-02-26)+4.0 pts
- If next-quarter guidance is cut (currently NEW as of 2026-02-26)-8.0 pts
- If labor state reverses from -0.31 (negative) to +0.31 (positive)-6.8 pts
- If health_care sector trend falls from +0.06 into 'weakening' (<= -0.20)-5.0 pts
Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-04-2810d agoItem 2.02
Results of Operations and Financial Condition. On April 27, 2026, Universal Health Services, Inc. issued the press release attached hereto as Exhibit 99.1.
earnings preannouncementneutralscore 52 - 2026-04-2414d agoItem 1.01
Entry into a Material Definitive Agreement Senior Secured Credit Facility On April 22, 2026, Universal Health Services, Inc. (the “Company”) entered into a Eleventh Amendment and Increased Facility Activation Notice (the “Eleventh Amendment”) to its Credit Agreement, dated as of November 15, 2010 (as amended by the First Amendment dated as of March 15, 2011, the Second Amendment dated as of September 21, 2012, the Third Amendment dated as of May 16, 2013, the Fourth Amendment dated as of Augu…
capital allocationneutralscore 47 - 2026-04-2414d agoItem 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in response to
capital allocationnegativescore 37 - 2026-03-301mo agoItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 2026 Annual Incentive Bonus Performance Goals On March 26, 2026, the Compensation Committee of the Board of Directors (the “Committee”) approved specific bonus formulae for the determination of annual incentive compensation for the Company’s executive officers for the year ending December 31, 2026, pursuant to the 2022 Executive Incentive Plan whic…
executive changeneutralscore 23 - 2026-02-262mo agoItem 2.02
Results of Operations and Financial Condition. On February 25, 2026, Universal Health Services, Inc. issued the press release attached hereto as Exhibit 99.1.
earnings preannouncementneutralscore 13
Score history
The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.